Comprehensive medication guide to Glycopyrronium including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$30 copay for generic oral tablets on most Tier 1–2 commercial and Medicare Part D plans. Qbrexza and COPD inhalers are typically Tier 3–4 and may require prior authorization; copays range from $25–$100+ without manufacturer savings cards.
Estimated Cash Pricing
$60–$95 retail for generic oral tablets (1 mg); as low as $12–$13 with GoodRx or SingleCare for a 30-day supply. Qbrexza topical cloths retail for $450–$600+ per month; Cuvposa oral solution retails for $450+ per month with GoodRx discounts to approximately $62.
Medfinder Findability Score
72/100
Summarize with AI
On this page
Glycopyrronium (also known as glycopyrrolate in the U.S.) is a synthetic anticholinergic medication belonging to the quaternary ammonium compound class. It works by competitively blocking muscarinic receptors throughout the body, reducing gland secretions, relaxing airway smooth muscle, and decreasing gastrointestinal motility.
One of its most important properties is that it does not cross the blood-brain barrier, which means it produces peripheral anticholinergic effects (on glands, airways, heart, and gut) without significant central nervous system effects — a key advantage over older anticholinergics like atropine and scopolamine.
Glycopyrronium is available under multiple brand names including Robinul (oral tablets), Cuvposa (pediatric oral solution), Dartisla ODT (orally disintegrating tablet), Qbrexza (topical cloth for hyperhidrosis), Seebri Neohaler and Lonhala Magnair (COPD inhalers), and Bevespi Aerosphere (combination COPD inhaler). Generic glycopyrrolate oral tablets and injectable solution are also widely available.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Glycopyrronium is a competitive muscarinic receptor antagonist. It blocks acetylcholine (the parasympathetic nervous system's main neurotransmitter) from binding to muscarinic receptors (M1, M2, and M3 subtypes) found throughout the body. By occupying these receptors without activating them, it prevents the "rest and digest" parasympathetic response in affected organs.
In the airways (COPD inhalers): blocking M3 receptors on airway smooth muscle causes bronchodilation, improving airflow. In sweat glands (Qbrexza): blocking M3 receptors reduces sweat secretion. In salivary glands (Cuvposa): blocking M1/M3 receptors reduces saliva production. Perioperatively (injectable): blocking M2 receptors at the SA node prevents vagally-mediated bradycardia; blocking M1/M3 in airway glands reduces secretions during intubation.
Its quaternary ammonium chemical structure carries a permanent positive charge that prevents significant passage across the blood-brain barrier, confining its effects to the peripheral nervous system and minimizing central side effects.
1 mg — tablet
Oral tablet (Robinul, generic) — for peptic ulcer adjunct
2 mg — tablet
Oral tablet (Robinul Forte, generic) — for peptic ulcer adjunct
1 mg/5 mL — oral solution
Cuvposa — for pediatric sialorrhea (ages 3–16)
2.4% — topical cloth
Qbrexza — for primary axillary hyperhidrosis (adults and ages 9+)
15.6 mcg — inhalation powder
Seebri Neohaler — COPD maintenance, twice daily
25 mcg/mL — inhalation solution
Lonhala Magnair — COPD maintenance via nebulizer, twice daily
9 mcg/4.8 mcg — inhalation aerosol
Bevespi Aerosphere — COPD maintenance (glycopyrrolate + formoterol), twice daily
0.2 mg/mL — injection
Injectable solution — perioperative use (IV/IM)
Availability varies significantly by formulation. Generic glycopyrrolate oral tablets (1 mg and 2 mg) are generally available at large retail pharmacy chains without significant access barriers — they are manufactured by multiple generic companies and priced affordably. However, specialty formulations can be harder to find.
Qbrexza (topical cloth) is not stocked at most retail pharmacies — patients must use specialty or mail-order pharmacies. Cuvposa (pediatric oral solution) may require advance ordering at retail pharmacies. Injectable glycopyrrolate has historically had supply disruptions due to the limited sterile manufacturing base for injectable drugs. COPD inhalers are generally available at pharmacies that stock respiratory medications.
If you're having trouble locating your specific glycopyrronium formulation, medfinder can call pharmacies near you to check which ones have it in stock and text you the results.
Glycopyrronium is not a controlled substance, so any licensed prescriber with a valid DEA registration can prescribe it. There are no federal scheduling restrictions or special prescriber certifications required. Prescriber types vary by indication:
Dermatologists — Primary prescribers for Qbrexza (hyperhidrosis)
Pediatric neurologists / Developmental pediatricians — Cuvposa for sialorrhea in neurological conditions
Pulmonologists / Respiratory specialists — Inhaled glycopyrronium for COPD maintenance
Anesthesiologists / CRNAs — Injectable perioperative use
Primary care physicians (PCPs), Nurse Practitioners (NPs), Physician Assistants (PAs) — May prescribe for any indication; common for oral tablet and COPD inhaler maintenance
Adult neurologists — Drooling in adults with ALS, Parkinson's disease, or other neurological conditions
Telehealth prescribing is available for many glycopyrronium indications, including hyperhidrosis (via telehealth dermatology platforms) and COPD maintenance (established patients via telehealth follow-up). Initial COPD diagnosis and spirometry must be done in person. Pediatric sialorrhea typically requires initial in-person specialist evaluation.
No. Glycopyrronium (glycopyrrolate) is not a controlled substance and has no DEA scheduling. It is not habit-forming, has no abuse potential, and is not regulated under the Controlled Substances Act. Any licensed prescriber — including physicians, nurse practitioners, and physician assistants — can prescribe it without special DEA registration requirements for controlled substances.
There are no federal refill restrictions on glycopyrronium prescriptions. Patients can receive multiple refills on a single prescription, though some states may have specific rules for certain prescriber types. Because it is not a controlled substance, it can also be prescribed via telehealth without the special restrictions that apply to controlled substance telehealth prescribing.
Glycopyrronium's anticholinergic mechanism produces predictable side effects across organ systems:
Dry mouth (xerostomia) — very common
Constipation
Urinary hesitancy / difficulty urinating
Blurred vision
Flushing and nasal congestion
Headache
Nausea, diarrhea
Irritability (especially in pediatric patients)
Heat prostration / heat stroke (impaired sweating in hot environments — call 911)
Urinary retention (complete inability to urinate — seek emergency care)
Acute angle-closure glaucoma (eye pain, halos, vision changes — seek emergency care)
Tachycardia / cardiac arrhythmias
Toxic megacolon (in patients with ulcerative colitis)
Know what you need? Skip the search.
Tiotropium (Spiriva)
LAMA for COPD; once-daily dry powder or soft mist inhaler; most widely used LAMA; substitutable for COPD inhaled glycopyrronium
Umeclidinium (Incruse Ellipta)
Once-daily LAMA for COPD; available in combination inhalers (Anoro, Trelegy); cannot be combined with glycopyrronium inhalers
Oxybutynin
Anticholinergic used off-label for hyperhidrosis; generic, inexpensive; also approved for overactive bladder; crosses BBB more than glycopyrronium
OnabotulinumtoxinA (Botox)
FDA-approved for axillary hyperhidrosis; injected into underarm; lasts 4–7 months per treatment; used as alternative when topical agents fail
Atropine
Anticholinergic; crosses BBB (more CNS effects); used perioperatively as substitute for glycopyrrolate when injectable unavailable
Prefer Glycopyrronium? We can find it.
Other anticholinergic drugs (oxybutynin, diphenhydramine, tolterodine, benztropine, amantadine)
majorAdditive anticholinergic effects — dry mouth, constipation, urinary retention, tachycardia, confusion
Solid oral potassium chloride (wax matrix tablets)
majorSlowed GI transit can cause KCl to remain in GI tract too long, risking GI lesions — contraindicated with Cuvposa
Umeclidinium-containing inhalers (Incruse Ellipta, Anoro Ellipta, Trelegy Ellipta)
majorDuplicate LAMA therapy — contraindicated; no added benefit, increased anticholinergic risk
Glucagon (intranasal or injectable)
majorAdditive GI motility inhibition — increased risk of severe GI adverse reactions
Metformin
moderateGlycopyrronium may increase metformin plasma levels via reduced renal tubular secretion — monitor glucose response
Atenolol
moderateGlycopyrronium increases atenolol bioavailability — may lower BP/HR more than expected
Digoxin (slow-dissolution tablets)
moderateIncreased digoxin absorption due to slowed GI transit — monitor digoxin levels
Haloperidol and antipsychotics with anticholinergic activity
moderateAdditive anticholinergic burden — increased risk of urinary retention, constipation, cognitive effects
Pramlintide
moderateAdditive gastric emptying delay — may impair glucose management
Glycopyrronium is a versatile anticholinergic with applications across anesthesiology, pulmonology, dermatology, pediatric neurology, and general medicine. Its ability to act peripherally without crossing the blood-brain barrier makes it preferable to atropine and scopolamine in many clinical settings. Its multiple formulations — tablets, oral solution, topical cloth, inhalation devices, and injectable — make it one of the most formulation-diverse drugs in outpatient and inpatient medicine.
For patients, the key considerations are: (1) knowing which formulation you're on and where to fill it — specialty products like Qbrexza require specialty pharmacies; (2) understanding that anticholinergic side effects are dose-dependent and cumulative with other anticholinergic drugs; and (3) knowing the serious heat stroke risk associated with reduced sweating.
If you're having trouble finding your glycopyrronium prescription in stock, medfinder calls pharmacies near you to check which ones have your specific formulation and texts you the results — saving you the time of calling each pharmacy yourself.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini